# Safety and Efficacy of Conestat Alfa for ACE-Induced Angioedema

> **NCT06679426** · PHASE3 · NOT_YET_RECRUITING · sponsor: **University of Cincinnati** · enrollment: 24 (estimated)

## Conditions studied

- ACE Inhibitor-Induced Angioedema

## Interventions

- **DRUG:** Conestat Alfa

## Key facts

- **NCT ID:** NCT06679426
- **Lead sponsor:** University of Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2024-11-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06679426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06679426, "Safety and Efficacy of Conestat Alfa for ACE-Induced Angioedema". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06679426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*